Influence of ciglitazone on A549 cells growthin vitro andin vivo and mechanism

Abstract

The effect and mechanism of the ciglitazone on lung cancer cells A549 growthin vitro andin vivo were studied. Various concentrations of ciglitazone were added to the cultured A549 line, and the proliferation and differentiation of A549 cells were examined by MTT and cytometry analysis. A549 cells (1×10⁶/mouse) were inoculated subcutaneously into 20 nude mice, which were randomly divided into two groups: the control group, the ciglitazone treated group. The weights of subcutaneous tumors were measured. The expression of cyclin D1 and P21 in the lung was detected by immohistochemistry and Western blot respectively. The results showed that the proliferation of A549 was inhibited significantly by ciglitazone in a dose- and time-dependent manner. There were more cells arrested in G₁/G₀ phase and the expression of PPARγ was markedly up-regulated in ciglitazone-treated group. Direct injection of ciglitazone into A549-induced tumors could suppress tumor growth in nude mice and the growth inhibitory rate was 36%. The expression of cyclin D1 was decreased and P21 increased significantly in ciglitazone-treated group as compared with control group. It was concluded that ciglitazone could inhibit A549 proliferation dose-dependently and time-dependently and induce differentiation, which might be related to the modulation of cell cycle interfered by PPARγ.

Keywords

peroxisome proliferator activated receptor γ / ciglitazone / cyclin D1 / P21

References

[1] KliewerS A, LenhardJ M, WillsonT M, et al.. A prostaglandin J2 metabolite binds peroxisome proliferator activated receptor gamma and promotes adipocyte differentiation. Cell, 1995, 83(5): 813-819

[2] SchoonjansK, StacksB, AuwersJ. The peroxisome proliferator activated receptors (PPARS) and their effects on lipid metabolism and adipocyte differentiation. Biochim Biophys Acta, 1996, 1302(2): 93-109

[3] JiangC, TingA T, SeedB. PPAR gamma agonists inhibit production of monocyte inflammatory cytokines. Nature, 1998, 391(6662): 82-86

[4] RicoteM, LiA C, WillsonT M, et al.. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature, 1998, 391(6662): 79-82

[5] GreeneM E, BlumbergB, McBrideO W, et al.. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr, 1995, 4(4–5): 281-299

[6] DuBoisR N, GuptaR, BrockmanJ, et al.. The nuclear eicosanoid receptor, PPARgamma, is aberrantly expressed in colonic cancers. Carcinogenesis, 1998, 19(1): 49-53

[7] SokolowskaM, KowalskiM L, PawliczakR, et al.. Peroxisome proliferator activated receptors-gamma (PPAR-gamma) and their role in immunoregulation and inflammation control. Postepy Hig Med Dosw, 2005, 59: 472-484

[8] MarxN, SchonbeckU, LazarM A, et al.. Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells. Circ Res, 1998, 83(11): 1097-1103

[9] MarxN, BourcierT, SukhovaG K, et al.. PPARgamma activation in human endothelial cells increases plasminogen activator inhibitor type-1 expression: PPARgamma as a potential mediator in vascular disease. Arterioscler Thromb Vasc Biol, 1999, 19(3): 546-551

[10] MaxwellP H, DachsG U, GleadleJ M, et al.. Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth. Proc Natl Acad Sci USA, 1997, 94(15): 8104-8109

[11] MuellerE, SarrafP, TontonozP, et al.. Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell, 1998, 1(3): 465-470

[12] BrockmanJ A, GuptaR A, DuboisR N. Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology, 1998, 115(5): 1049-1055

[13] SarrafP, MuellerE, SmithW M, et al.. Loss-of-function mutations in PPAR gamma associated with human colon cancer. Mol Cell, 1999, 3(6): 799-804

[14] AltiokS, XuM, SpiegelmanB H. PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev, 1997, 11(15): 1987-1998

[15] ShappellS B, GuptaR A, ManningS, et al.. 15S-Hydroxyeicosatetracnoic acid activates peroxisome proliferator-activated receptor gamma and inhibits proliferation in PC3 prostate carcinoma cells. Cancer Res, 2001, 61(2): 497-503